Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Research shows 40% decline in colorectal cancer diagnoses during COVID-19 pandemic

The number of colorectal cancer (CRC) cases diagnosed fell dramatically by 40% in a year during the COVID-19 pandemic, new research presented today at UEG Week Virtual 2021 has shown.

4 Oct 2021

Research finds possible connection between bacteria and bowel cancer

New research from RCSI University of Medicine and Health Sciences has found a possible relationship between the presence of a specific type of bacteria found in tumors and the spread of bowel cancer.

1 Oct 2021

Research shows dramatic decline in colorectal cancer diagnoses during the pandemic

The number of colorectal cancer cases diagnosed fell dramatically by 40% in a year during the COVID-19 pandemic, new research presented today at UEG Week Virtual 2021 has shown.

1 Oct 2021

$94 million PCORI funding to support the next phase of PCORnet and new colorectal cancer study in older adults

The Patient-Centered Outcomes Research Institute Board of Governors today approved $61.3 million for a slate of several infrastructure projects that will support the activities of eight Clinical Research Networks to implement the next phase of PCORnet, the National Patient-Centered Clinical Research Network.

29 Sep 2021

Researchers detect two types of RNA base modifications simultaneously using a quantum sequencer

After a gene is transcribed into RNA, modifications can occur to the subunits or "bases" that make up the RNA molecule, which can affect its structure and function. The study of these changes is known as "epitranscriptomics." These base modifications can occur to most types of RNA molecules, including microRNAs.

29 Sep 2021

Researchers compare transcriptomic and cytokine responses of colorectal cancer cells

Oncotarget published "Pan-drug and drug-specific mechanisms of 5-FU, irinotecan (CPT-11), oxaliplatin, and cisplatin identified by comparison of transcriptomic and cytokine responses of colorectal cancer cells" which reported that there was an increase in IL-8 by oxaliplatin and increase in ferritin by cisplatin which may contribute to cancer cell survival.

29 Sep 2021

Research provides the basis for an additional novel immunotherapy for multiple myeloma patients

Oncotarget published "Multipeptide stimulated PBMCs generate TEM/TCM for adoptive cell therapy in multiple myeloma" which reported that Multiple Myeloma patients suffer disease relapse due to the development of therapeutic resistance. Increasing evidence suggests that immunotherapeutic strategies can provide durable responses.

29 Sep 2021

Doubling excise duties could prevent alcohol-attributable cancers

In a recent modeling study, scientists at Technische Universität Dresden have examined the impact of increasing taxes on alcoholic beverages on alcohol-attributable cancers in the World Health Organization (WHO) European Region.

22 Sep 2021

Hispanic Americans have a higher risk of preventable infection-related cancers, report shows

A new report shows that although Hispanic men and women in the continental United States and Hawaii have 25% to 30% lower overall cancer incidence and mortality than non-Hispanic Whites, they continue to have a higher risk of potentially preventable, infection-related cancers, including approximately two-fold higher rates of liver and stomach cancers.

21 Sep 2021

Artificial intelligence predicts the risk of metastatic relapse in breast cancer patients

The RACE AI study conducted by Gustave Roussy and the startup Owkin, as part of the AI for Health Challenge organized by the Ile-de-France Region in 2019, was presented as a proffered paper at ESMO.

21 Sep 2021

Researchers reveal a mechanism of SHP2-mediated tumor immunosuppression

Colorectal cancer (CRC), a malignant tumor worldwide consists of microsatellite instability (MSI) and stable (MSS) phenotypes. Although SHP2 is a hopeful target for cancer therapy, its relationship with innate immunosuppression remains elusive. To address that, the authors of this article performed single-cell RNA sequencing to explore the role of SHP2 in all cell types of tumor microenvironment (TME) from murine MC38 xenografts.

21 Sep 2021

Increased presence of certain bacteria in the gut may indicate colon cancer risk

A study published today in the journal Cell Host & Microbe reported that the increased presence of certain bacteria in a gut biome indicates a greater likelihood that colon polyps will become cancerous.

18 Sep 2021

MS patients diagnosed with colorectal cancer may have shorter survival times, study finds

People with multiple sclerosis (MS) who are diagnosed with colorectal cancer may be at a higher risk of dying from cancer or other causes over the next six months to one year than people with colorectal cancer who do not have MS, according to a study published in the September 15, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.

16 Sep 2021

Colorectal Cancer Project launches to improve understanding of the disease and accelerate research

Count Me In, a nonprofit cancer research initiative, is inviting all patients across the United States and Canada who have ever been diagnosed with colorectal cancer to participate in research and help drive new discoveries related to this disease.

14 Sep 2021

Researchers discover new pathway that makes drugs less effective in bowel cancer patients

Leading scientists at the University of Birmingham have discovered a previously unknown pathway that prevents specific drugs from working in patients with bowel cancer.

14 Sep 2021

Second- or third-degree relatives could influence a person's risk of developing colorectal cancer

Having second- or third-degree relatives with colorectal cancer increases a person's risk of developing the disease, according to the findings of a study led by researchers from the University at Buffalo and the University of Utah.

13 Sep 2021

New imaging technique uses photonics for early diagnosis of bowel cancer

Early intervention could prevent many of the 160,000 deaths from colon cancer in Europe each year. Colonoscopies, the gold standard for spotting bowel cancer early, can still miss up to 20% of precancerous cells.

7 Sep 2021

Simple, non-invasive tool obviates unnecessary surgery in patients with colorectal cancer

A blood RNA test predicts whether residual tumour cells remain in early-stage colon cancer patients and obviates unnecessary surgery.

6 Sep 2021

Impact of neoadjuvant concurrent chemoradiation on exosomal markers expression in colorectal cancer

Oncotarget published "The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma" which reported that the impact of neoadjuvant concurrent chemoradiation on exosomal markers expression and their prognostic significance in patients with rectal adenocarcinoma are yet to be explored.

1 Sep 2021

Research confirms link between antibiotic use and increased risk of colon cancer

There is a clear link between taking antibiotics and an increased risk of developing colon cancer within the next five to ten years. This has been confirmed by researchers at Umeå University, Sweden, after a study of 40,000 cancer cases. The impact of antibiotics on the intestinal microbiome is thought to lie behind the increased risk of cancer.

1 Sep 2021

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Research shows 40% decline in colorectal cancer diagnoses during COVID-19 pandemic

Research finds possible connection between bacteria and bowel cancer

Research shows dramatic decline in colorectal cancer diagnoses during the pandemic

$94 million PCORI funding to support the next phase of PCORnet and new colorectal cancer study in older adults

Researchers detect two types of RNA base modifications simultaneously using a quantum sequencer

Researchers compare transcriptomic and cytokine responses of colorectal cancer cells

Research provides the basis for an additional novel immunotherapy for multiple myeloma patients

Doubling excise duties could prevent alcohol-attributable cancers

Hispanic Americans have a higher risk of preventable infection-related cancers, report shows

Artificial intelligence predicts the risk of metastatic relapse in breast cancer patients

Researchers reveal a mechanism of SHP2-mediated tumor immunosuppression

Increased presence of certain bacteria in the gut may indicate colon cancer risk

MS patients diagnosed with colorectal cancer may have shorter survival times, study finds

Colorectal Cancer Project launches to improve understanding of the disease and accelerate research

Researchers discover new pathway that makes drugs less effective in bowel cancer patients

Second- or third-degree relatives could influence a person's risk of developing colorectal cancer

New imaging technique uses photonics for early diagnosis of bowel cancer

Simple, non-invasive tool obviates unnecessary surgery in patients with colorectal cancer

Impact of neoadjuvant concurrent chemoradiation on exosomal markers expression in colorectal cancer

Research confirms link between antibiotic use and increased risk of colon cancer

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in